216 related articles for article (PubMed ID: 15669182)
1. Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction.
Zhao HM; Liu XF; Mao XW; Chen CF
Chin Med Sci J; 2004 Dec; 19(4):257-61. PubMed ID: 15669182
[TBL] [Abstract][Full Text] [Related]
2. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
Liu XF; Fawcett JR; Thorne RG; DeFor TA; Frey WH
J Neurol Sci; 2001 Jun; 187(1-2):91-7. PubMed ID: 11440750
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke.
Cheng S; Ma M; Ma Y; Wang Z; Xu G; Liu X
Neurol Res; 2009 Sep; 31(7):753-8. PubMed ID: 19061539
[TBL] [Abstract][Full Text] [Related]
4. Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia.
Zhu W; Cheng S; Xu G; Ma M; Zhou Z; Liu D; Liu X
Drug Deliv; 2011 Jul; 18(5):338-43. PubMed ID: 21348576
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion.
Liu XF; Fawcett JR; Thorne RG; Frey WH
Neurosci Lett; 2001 Aug; 308(2):91-4. PubMed ID: 11457567
[TBL] [Abstract][Full Text] [Related]
6. Intranasal wnt3a Attenuates Neuronal Apoptosis through Frz1/PIWIL1a/FOXM1 Pathway in MCAO Rats.
Matei N; Camara J; McBride D; Camara R; Xu N; Tang J; Zhang JH
J Neurosci; 2018 Jul; 38(30):6787-6801. PubMed ID: 29954850
[TBL] [Abstract][Full Text] [Related]
7. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
8. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Acta Neurochir Suppl; 2000; 76():331-3. PubMed ID: 11450037
[TBL] [Abstract][Full Text] [Related]
9. [The effect of butylphthalide on expression of NGF and BDNF in ischemia stroke tissue of rat cerebrum].
Kong SY; Li QF; Yang J; He L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):400-3, 407. PubMed ID: 17593816
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Calcitonin Gene-Related Peptide Protects Against Focal Cerebral Ischemic Injury in Rats Through the Wnt/β-Catenin Pathway.
Du Z; Zhang H; Chen Q; Gao Y; Sun B
Med Sci Monit; 2018 Dec; 24():8860-8869. PubMed ID: 30531687
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
[TBL] [Abstract][Full Text] [Related]
12. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
[TBL] [Abstract][Full Text] [Related]
13. [Effects of tetrahydroxystilbene glucoside on nerve growth factor and growth associated protein in rats after cerebral ischemia-reperfusion].
Zhou ZW; Yang J; Yang QD; Zeng J; Zheng LJ
Zhong Yao Cai; 2010 Jul; 33(7):1120-4. PubMed ID: 21137370
[TBL] [Abstract][Full Text] [Related]
14. Emulsified Isoflurane Protects Against Transient Focal Cerebral Ischemia Injury in Rats via the PI3K/Akt Signaling Pathway.
Zhang H; Xiong X; Liu J; Gu L; Li F; Wan Y; Xu S
Anesth Analg; 2016 May; 122(5):1377-84. PubMed ID: 26859875
[TBL] [Abstract][Full Text] [Related]
15. Acidic fibroblast growth factor delivered intranasally induces neurogenesis and angiogenesis in rats after ischemic stroke.
Cheng X; Wang Z; Yang J; Ma M; Lu T; Xu G; Liu X
Neurol Res; 2011 Sep; 33(7):675-80. PubMed ID: 21756545
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
[TBL] [Abstract][Full Text] [Related]
17. The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.
Yang JP; Liu HJ; Wang ZL; Cheng SM; Cheng X; Xu GL; Liu XF
Neurosci Lett; 2009 Sep; 461(3):212-6. PubMed ID: 19559076
[TBL] [Abstract][Full Text] [Related]
18. Effect of electroacupuncture on the expression of Nav1.1 in rat after acute cerebral ischemia.
Ren L; Fang Yn; Zhang Aw; Li Xl; Wang Xj; Yin Z; Miao Jy
Neurol Res; 2010 Sep; 32(7):763-9. PubMed ID: 19703358
[TBL] [Abstract][Full Text] [Related]
19. Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia.
Ma YP; Ma MM; Cheng SM; Ma HH; Yi XM; Xu GL; Liu XF
Neurosci Lett; 2008 May; 437(2):93-7. PubMed ID: 18436379
[TBL] [Abstract][Full Text] [Related]
20. Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
J Cereb Blood Flow Metab; 2004 Jan; 24(1):114-23. PubMed ID: 14688623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
